mef 2d Search Results


93
Santa Cruz Biotechnology mef2d
The p38 pathway and <t>Mef2D</t> are rate-limiting for late-stage genes. (A) Examples of simple network motifs based on Lee et al. (2002). In a single-input motif, factor A directly regulates the three targets B, C, and D. The simple cascade depicts sequential activation with only gene B directly activated by A. In the feed-forward loop, A directly regulates each gene and sequential activation is achieved by requiring both A and B to express gene C, and both A and C to express gene D. (B) MDER fibroblasts were induced to differentiate for varying times and analyzed by Northern and Western blot. (SB) Treatment of cells with SB203580; (CIP) phosphatase treatment prior to SDS-PAGE. (C) Ratio of the average gene expression in each temporal cluster of MyoD-activated genes comparing cells constitutively expressing MKK6E or treated with SB203580 with the expression in untreated cells, demonstrating effects of p38 activity on clusters of genes activated at different stages of differentiation. Ratios are in log2 space; a value of 0 indicates no treatment change, a value of 1 indicates a twofold increase due to the treatment, and a value of -1 indicates a twofold reduction. Microarray expression data was generated from MDER cells induced to differentiate for 24 h with MKK6E-expressing virus or control virus, and analyzed together with previously generated data for control and SB203580-treated MDER cells (Bergstrom et al. 2002). Clusters 1-6 are the earliest to latest activated clusters, and cluster 7 is a transiently expressed group of genes (Bergstrom et al. 2002). Error bars represent standard error, except cluster 7, where error bars are absent because only one gene from this cluster was affected. ANOVA p-value < 0.0001 for both MKK6E and SB203580. Post-hoc testing indicated that cluster 6 differs significantly from the other clusters in response to MKK6E. (D) MDER cells were infected with the indicated retroviruses, induced to differentiate for 12 h, and subjected to Northern analysis for late-stage genes Myh3 and Des and the early-stage gene Cdh15. Mef2 is the Mef2D isoform, Con is an empty control retrovirus.
Mef2d, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mef2d/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
mef2d - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier

91
Santa Cruz Biotechnology mef2d specific crispr cas9 knockout
a <t>Mef2D</t> is extensively disordered and predicted to form liquid-liquid phase separated condensates. The Mef2D structure predicted by Alphafold indicates a small structured domain involving the N-terminal ~100 residues and most of the transactivation domain (TAD) contains is disordered. The regions promoting formation of liquid-like droplets by the FuzDrop method are marked by blue. The β-domain (magenta) appears as an ordered motif within the disordered transactivation region. FuzDrop predictions shown on the right panels indicate high droplet-promoting probability (p DP ) in particular for regions 155-268 residues and 341-520 residues, which are predicted to spontaneously form liquid-liquid phase separated condensates. The β-domain (magenta) and its flanking regions (cyan) are predicted to serve as ordered interaction motifs within the condensate (see also Supplementary Fig. ). In addition, the β-domain region is capable of sampling a multiplicity of binding modes (MBM), indicating its sensitivity to the cellular context. b Sequences of the designed Mef2D variants. The β-domain and its flanking regions are shown for the wild-type ( wt ) Mef2D (UniProt code: Q14814; https://legacy.uniprot.org/uniprot/Q14814 ; 265-301 residues), var1 and var2 with similar β-domain dynamics (gray), var3 and var4 with mobile β-domains (green), var5 - var8 with rigid β-domains (red) as compared to wild-type Mef2D. The sequence of the β-domain is magenta, mutated residues (orange) are highlighted. c Predicted β-domain disorder of Mef2D variants. Structural disorder in the unbound state of Mef2D were computed for the full protein sequence using the Espritz method as embedded in the FuzPred program and the p D values were averaged for residues 286-292. The var3 and var4 variants (green) are above the threshold between disorder and order (p D ≥ 0.3085 ). var1 (gray) has similar, var2 (gray) has slightly more mobile β-domain than the wild-type Mef2D (black). var5 - var8 variants (red) are predicted to have more rigid β-domain than the wild-type. d Droplet landscape of the Mef2D variants. The droplet landscape shows the droplet probability (p DP ) as a function of the multiplicity of binding modes (MBM) , . The assemblies below the diagonal are likely more solid-like, those above the diagonal are more liquid like . High MBM values indicate an increased likelihood to change between liquid-like and solid-like forms, for example in case of var8 . More mobile β-domain variants ( var3 , var4 , green diamonds) exhibit increased probability to form droplets (higher p DP ), whereas more rigid β-domain variants ( var5 - var8 , red triangles) more likely form solid-like states depending on the cellular conditions (high MBM).
Mef2d Specific Crispr Cas9 Knockout, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mef2d specific crispr cas9 knockout/product/Santa Cruz Biotechnology
Average 91 stars, based on 1 article reviews
mef2d specific crispr cas9 knockout - by Bioz Stars, 2026-03
91/100 stars
  Buy from Supplier

91
Boster Bio primary antibodies against mef2d
Fig. 5. Dex reversed H/R-induced upre gulation of miR-665 and downregulation of <t>MEF2D.</t> (A-B) Expressions of miR-665 and MEF2D mRNA were examined by qRT-PCR. (C-D) Expressions of <t>MEF2D</t> <t>protein</t> were detected by Western blot. Quantitative analyses of protein band intensity. GAPDH served as an internal control for sample loading. (E) Predicted duplex formation between MEF2D 3′- UTR and miR-665. (F) Dual luciferase gene reporter assay manifested that miR- 665 could directly bind with MEF2D. (n = 3 per group). **p < 0.01, ***p < 0.001, ****p < 0.0001. qRT- PCR, quantitative reverse transcription PCR; UTR, untranslated region; MEF2D, myocyte enhancer factor 2D.
Primary Antibodies Against Mef2d, supplied by Boster Bio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies against mef2d/product/Boster Bio
Average 91 stars, based on 1 article reviews
primary antibodies against mef2d - by Bioz Stars, 2026-03
91/100 stars
  Buy from Supplier

92
Santa Cruz Biotechnology mef2d sirna
Neuritin induces LGI1 expression through HDAC5 phosphorylation and <t>MEF2D-mediated</t> transcription. (A) Representative immunoblots of p-HDAC5 in hippocampal neurons (DIV7) treated with various concentrations of recombinant soluble neuritin for 30 min or with KCl (30 mM) for 6 h ( n = 4–5). (B) Representative immunoblots of p-HDAC5 from hippocampal neurons pretreated with KN-62 (30 μM) or Gö6976 (1 μM) for 30 min and incubated with soluble neuritin or KCl ( n = 3). (C–E) Luciferase assays. MEF2-luiciferase activity was normalized with Renilla luciferase activity and is depicted relative to the control (CTL), and expressed as fold change relative to the CTL. (C) Mouse hippocampal neurons (DIV4) transfected with pGL3-Luc and pGL3-MEF2-Luc were treated with neuritin for the indicated times ( n = 4). (D) Mouse hippocampal neurons transfected with pGL3-Luc and PGL3- MEF2 -Luc were treated with neuritin in the presence of KN-62 or Gö6976 ( n = 4). (E) Neurons transfected with pGL3-Luc, pGL3- MEF2 -Luc, pCl-neo, pCl-neo- HDAC5 -WT or pCl-neo- HDAC5 -S/A were treated with recombinant soluble neuritin for 1 h ( n = 7). (F) ChIP assays. Binding of HDAC5 to the Lgi1 promoter was decreased in recombinant soluble neuritin-treated mouse hippocampal neurons ( n = 3). (G) IP. Neurons (DIV4) transfected with Myc- HDAC5 were treated with recombinant soluble neuritin (200 ng/ml) for 1 h. Binding of HDAC5 to MEF2D in mouse hippocampal neurons was decreased by recombinant soluble neuritin treatment ( n = 3). (H) Neurons (DIV4) transfected with control siRNA and Mef2d siRNA were treated with recombinant soluble neuritin (200 ng/ml) for 6 h. Representative immunoblots (Left) and quantitative data (Right) for MEF2D or LGI1 protein expression ( n = 3). In (A)–(H), Data are represented as mean ± SEM; * p < 0.05, ** p < 0.01, *** p < 0.001 compared with CTL, # p < 0.05, ### p < 0.001 compared with recombinant soluble neuritin treatment. Statistics: Student's t -test (A, C, F and G). One-way ANOVA (B) or two-way ANOVA (D) followed by LSD posttest. Two-way ANOVA followed by Newman-Keuls posttest (E) or Bonferroni posttest (H). Statistics detailed in .
Mef2d Sirna, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mef2d sirna/product/Santa Cruz Biotechnology
Average 92 stars, based on 1 article reviews
mef2d sirna - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier

92
Santa Cruz Biotechnology mef 2d
Exogenous stable expression of GRIP-1 sense and antisense in C2C12 myogenic cells demonstrates that GRIP-1 expression is necessary for terminal skeletal muscle cell differentiation. Total RNA was isolated from both normal C2C12 and stably transfected C2:GRIP-1 sense and antisense cells at the PMB and CMB stage (∼50% and 100% confluent, respectively) cultured in growth medium, and at a stage 72 hr/3 days after the withdrawal of serum (i.e., propagated in differentiation medium, MT-3). RNA samples were blotted and probed with 32P-radiolabeled cDNA encoding GAPDH, myoD, myogenin, cyclinD1, and p21. <t>MEF-2</t> proteins were detected by Western blot with 30 μg of nuclear proteins from each sample using a rabbit antibody to MEF-2 (Santa Cruz C-21), which was generated against MEF-2A but which cross-reacts with mouse/human MEF-2A, MEF-2C, and <t>MEF-2D.</t> (GM) Growth medium (DMEM containing 20% FCS); (DM) differentiation medium (DMEM containing 2% horse serum).
Mef 2d, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mef 2d/product/Santa Cruz Biotechnology
Average 92 stars, based on 1 article reviews
mef 2d - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier

Image Search Results


The p38 pathway and Mef2D are rate-limiting for late-stage genes. (A) Examples of simple network motifs based on Lee et al. (2002). In a single-input motif, factor A directly regulates the three targets B, C, and D. The simple cascade depicts sequential activation with only gene B directly activated by A. In the feed-forward loop, A directly regulates each gene and sequential activation is achieved by requiring both A and B to express gene C, and both A and C to express gene D. (B) MDER fibroblasts were induced to differentiate for varying times and analyzed by Northern and Western blot. (SB) Treatment of cells with SB203580; (CIP) phosphatase treatment prior to SDS-PAGE. (C) Ratio of the average gene expression in each temporal cluster of MyoD-activated genes comparing cells constitutively expressing MKK6E or treated with SB203580 with the expression in untreated cells, demonstrating effects of p38 activity on clusters of genes activated at different stages of differentiation. Ratios are in log2 space; a value of 0 indicates no treatment change, a value of 1 indicates a twofold increase due to the treatment, and a value of -1 indicates a twofold reduction. Microarray expression data was generated from MDER cells induced to differentiate for 24 h with MKK6E-expressing virus or control virus, and analyzed together with previously generated data for control and SB203580-treated MDER cells (Bergstrom et al. 2002). Clusters 1-6 are the earliest to latest activated clusters, and cluster 7 is a transiently expressed group of genes (Bergstrom et al. 2002). Error bars represent standard error, except cluster 7, where error bars are absent because only one gene from this cluster was affected. ANOVA p-value < 0.0001 for both MKK6E and SB203580. Post-hoc testing indicated that cluster 6 differs significantly from the other clusters in response to MKK6E. (D) MDER cells were infected with the indicated retroviruses, induced to differentiate for 12 h, and subjected to Northern analysis for late-stage genes Myh3 and Des and the early-stage gene Cdh15. Mef2 is the Mef2D isoform, Con is an empty control retrovirus.

Journal:

Article Title: A MyoD-generated feed-forward circuit temporally patterns gene expression during skeletal muscle differentiation

doi: 10.1101/gad.1234304

Figure Lengend Snippet: The p38 pathway and Mef2D are rate-limiting for late-stage genes. (A) Examples of simple network motifs based on Lee et al. (2002). In a single-input motif, factor A directly regulates the three targets B, C, and D. The simple cascade depicts sequential activation with only gene B directly activated by A. In the feed-forward loop, A directly regulates each gene and sequential activation is achieved by requiring both A and B to express gene C, and both A and C to express gene D. (B) MDER fibroblasts were induced to differentiate for varying times and analyzed by Northern and Western blot. (SB) Treatment of cells with SB203580; (CIP) phosphatase treatment prior to SDS-PAGE. (C) Ratio of the average gene expression in each temporal cluster of MyoD-activated genes comparing cells constitutively expressing MKK6E or treated with SB203580 with the expression in untreated cells, demonstrating effects of p38 activity on clusters of genes activated at different stages of differentiation. Ratios are in log2 space; a value of 0 indicates no treatment change, a value of 1 indicates a twofold increase due to the treatment, and a value of -1 indicates a twofold reduction. Microarray expression data was generated from MDER cells induced to differentiate for 24 h with MKK6E-expressing virus or control virus, and analyzed together with previously generated data for control and SB203580-treated MDER cells (Bergstrom et al. 2002). Clusters 1-6 are the earliest to latest activated clusters, and cluster 7 is a transiently expressed group of genes (Bergstrom et al. 2002). Error bars represent standard error, except cluster 7, where error bars are absent because only one gene from this cluster was affected. ANOVA p-value < 0.0001 for both MKK6E and SB203580. Post-hoc testing indicated that cluster 6 differs significantly from the other clusters in response to MKK6E. (D) MDER cells were infected with the indicated retroviruses, induced to differentiate for 12 h, and subjected to Northern analysis for late-stage genes Myh3 and Des and the early-stage gene Cdh15. Mef2 is the Mef2D isoform, Con is an empty control retrovirus.

Article Snippet: ChIP, Western, immunofluorescence, and antibodies Antibodies used for ChIP were as follows: Mef2A (Santa Cruz), note that this antibody also recognizes Mef2C and Mef2D (B.H.

Techniques: Activation Assay, Northern Blot, Western Blot, SDS Page, Expressing, Activity Assay, Microarray, Generated, Infection

Mef2D and p38 are rate limiting for the activation of late-stage genes. (A) MDER cells were infected with MKK6E and/or Mef2D-expressing retrovirus as indicated, induced to differentiate for varying lengths of time, and analyzed by Northern blot with the indicated probes. GFP is used as a control retrovirus. (B) MDER fibroblasts were transfected with the MKK6E and/or Mef2D retrovirus as indicated, induced to differentiate, and examined by immunofluorescence for the indicated late-stage (Myh3 and Des) and early-stage (Mgn) gene products. The bars indicate the average number of positive cells per field.

Journal:

Article Title: A MyoD-generated feed-forward circuit temporally patterns gene expression during skeletal muscle differentiation

doi: 10.1101/gad.1234304

Figure Lengend Snippet: Mef2D and p38 are rate limiting for the activation of late-stage genes. (A) MDER cells were infected with MKK6E and/or Mef2D-expressing retrovirus as indicated, induced to differentiate for varying lengths of time, and analyzed by Northern blot with the indicated probes. GFP is used as a control retrovirus. (B) MDER fibroblasts were transfected with the MKK6E and/or Mef2D retrovirus as indicated, induced to differentiate, and examined by immunofluorescence for the indicated late-stage (Myh3 and Des) and early-stage (Mgn) gene products. The bars indicate the average number of positive cells per field.

Article Snippet: ChIP, Western, immunofluorescence, and antibodies Antibodies used for ChIP were as follows: Mef2A (Santa Cruz), note that this antibody also recognizes Mef2C and Mef2D (B.H.

Techniques: Activation Assay, Infection, Expressing, Northern Blot, Transfection, Immunofluorescence

p38 regulates transcription factor recruitment. (A) MDER fibroblasts were either untreated (0 h) or infected with MKK6E retrovirus (+) or empty vector control retrovirus (-) and induced to differentiate for 12, 24, or 48 h. ChIP was performed with broad-specificity Mef2 antiserum, and multiplex PCR for the indicated promoters was performed with pancreatic amylase (Amy) as an internal control. Input chromatin was amplified over a 30-fold range to verify linearity of the assay. Graphs indicate IP promoter fold enrichment relative to input chromatin. Data for a representative ChIP are shown with error bars indicating S.E.M. for triplicate PCR. (B) Mef2 ChIP demonstrating that active MyoD is necessary for Mef2 binding, and that the broad-specificity Mef2 antisera identifies Mef2 binding both with and without exogenous Mef2D expression. (NS) Nonspecific IgG control ChIP; (E2) β-estradiol to induce MyoD activity. (C) ChIP using Mef2D monoclonal antibody shows Mef2D is not bound at early times in the absence of exogenous Mef2D. (GFP) A control retrovirus; (K6 + 2D or 6 + D) a combination of the MKK6E and Mef2D retroviruses. (D) ChIP using MyoD antisera shows p38 regulation of MyoD binding but no dependence on Mef2D. Input titration shown in C. (Empty) Control virus without effector gene.

Journal:

Article Title: A MyoD-generated feed-forward circuit temporally patterns gene expression during skeletal muscle differentiation

doi: 10.1101/gad.1234304

Figure Lengend Snippet: p38 regulates transcription factor recruitment. (A) MDER fibroblasts were either untreated (0 h) or infected with MKK6E retrovirus (+) or empty vector control retrovirus (-) and induced to differentiate for 12, 24, or 48 h. ChIP was performed with broad-specificity Mef2 antiserum, and multiplex PCR for the indicated promoters was performed with pancreatic amylase (Amy) as an internal control. Input chromatin was amplified over a 30-fold range to verify linearity of the assay. Graphs indicate IP promoter fold enrichment relative to input chromatin. Data for a representative ChIP are shown with error bars indicating S.E.M. for triplicate PCR. (B) Mef2 ChIP demonstrating that active MyoD is necessary for Mef2 binding, and that the broad-specificity Mef2 antisera identifies Mef2 binding both with and without exogenous Mef2D expression. (NS) Nonspecific IgG control ChIP; (E2) β-estradiol to induce MyoD activity. (C) ChIP using Mef2D monoclonal antibody shows Mef2D is not bound at early times in the absence of exogenous Mef2D. (GFP) A control retrovirus; (K6 + 2D or 6 + D) a combination of the MKK6E and Mef2D retroviruses. (D) ChIP using MyoD antisera shows p38 regulation of MyoD binding but no dependence on Mef2D. Input titration shown in C. (Empty) Control virus without effector gene.

Article Snippet: ChIP, Western, immunofluorescence, and antibodies Antibodies used for ChIP were as follows: Mef2A (Santa Cruz), note that this antibody also recognizes Mef2C and Mef2D (B.H.

Techniques: Infection, Plasmid Preparation, Multiplex Assay, Amplification, Binding Assay, Expressing, Activity Assay, Titration

Mef2D and p38 regulate Pol II recruitment and progression. (A) MDER cells were transduced with control (GFP), MKK6E (K6), and/or Mef2D (2D) retroviruses, induced to differentiate 12 h and ChIP for Pol II, or P-CTD Pol II performed. The combination of Mef2D and p38 is associated with Pol II recruitment and phosphorylation. (B) MDER cells were transduced with the indicated retroviruses and induced to differentiate for 16 h. At this later time point when endogenous Mef2D and other muscle-specific Mef2 isoforms are accumulating, p38 activation induces polymerase progression and accumularion of P-CTD Pol II in the 3′ end of the gene. ChIP performed for Pol II and Ser 5-phosphorylated Pol II (P-CTD Pol II). Amplification of the gene promoter and a region in the 3′-transcribed regions of the gene (exon 7 of desmin, 6.5 kb from the promoter, and exon 27 of MHC, 19 kb from the promoter) was performed. Titrations, internal control, and graphs are as previously indicated.

Journal:

Article Title: A MyoD-generated feed-forward circuit temporally patterns gene expression during skeletal muscle differentiation

doi: 10.1101/gad.1234304

Figure Lengend Snippet: Mef2D and p38 regulate Pol II recruitment and progression. (A) MDER cells were transduced with control (GFP), MKK6E (K6), and/or Mef2D (2D) retroviruses, induced to differentiate 12 h and ChIP for Pol II, or P-CTD Pol II performed. The combination of Mef2D and p38 is associated with Pol II recruitment and phosphorylation. (B) MDER cells were transduced with the indicated retroviruses and induced to differentiate for 16 h. At this later time point when endogenous Mef2D and other muscle-specific Mef2 isoforms are accumulating, p38 activation induces polymerase progression and accumularion of P-CTD Pol II in the 3′ end of the gene. ChIP performed for Pol II and Ser 5-phosphorylated Pol II (P-CTD Pol II). Amplification of the gene promoter and a region in the 3′-transcribed regions of the gene (exon 7 of desmin, 6.5 kb from the promoter, and exon 27 of MHC, 19 kb from the promoter) was performed. Titrations, internal control, and graphs are as previously indicated.

Article Snippet: ChIP, Western, immunofluorescence, and antibodies Antibodies used for ChIP were as follows: Mef2A (Santa Cruz), note that this antibody also recognizes Mef2C and Mef2D (B.H.

Techniques: Transduction, Activation Assay, Amplification

a Mef2D is extensively disordered and predicted to form liquid-liquid phase separated condensates. The Mef2D structure predicted by Alphafold indicates a small structured domain involving the N-terminal ~100 residues and most of the transactivation domain (TAD) contains is disordered. The regions promoting formation of liquid-like droplets by the FuzDrop method are marked by blue. The β-domain (magenta) appears as an ordered motif within the disordered transactivation region. FuzDrop predictions shown on the right panels indicate high droplet-promoting probability (p DP ) in particular for regions 155-268 residues and 341-520 residues, which are predicted to spontaneously form liquid-liquid phase separated condensates. The β-domain (magenta) and its flanking regions (cyan) are predicted to serve as ordered interaction motifs within the condensate (see also Supplementary Fig. ). In addition, the β-domain region is capable of sampling a multiplicity of binding modes (MBM), indicating its sensitivity to the cellular context. b Sequences of the designed Mef2D variants. The β-domain and its flanking regions are shown for the wild-type ( wt ) Mef2D (UniProt code: Q14814; https://legacy.uniprot.org/uniprot/Q14814 ; 265-301 residues), var1 and var2 with similar β-domain dynamics (gray), var3 and var4 with mobile β-domains (green), var5 - var8 with rigid β-domains (red) as compared to wild-type Mef2D. The sequence of the β-domain is magenta, mutated residues (orange) are highlighted. c Predicted β-domain disorder of Mef2D variants. Structural disorder in the unbound state of Mef2D were computed for the full protein sequence using the Espritz method as embedded in the FuzPred program and the p D values were averaged for residues 286-292. The var3 and var4 variants (green) are above the threshold between disorder and order (p D ≥ 0.3085 ). var1 (gray) has similar, var2 (gray) has slightly more mobile β-domain than the wild-type Mef2D (black). var5 - var8 variants (red) are predicted to have more rigid β-domain than the wild-type. d Droplet landscape of the Mef2D variants. The droplet landscape shows the droplet probability (p DP ) as a function of the multiplicity of binding modes (MBM) , . The assemblies below the diagonal are likely more solid-like, those above the diagonal are more liquid like . High MBM values indicate an increased likelihood to change between liquid-like and solid-like forms, for example in case of var8 . More mobile β-domain variants ( var3 , var4 , green diamonds) exhibit increased probability to form droplets (higher p DP ), whereas more rigid β-domain variants ( var5 - var8 , red triangles) more likely form solid-like states depending on the cellular conditions (high MBM).

Journal: Nature Communications

Article Title: Alternatively spliced exon regulates context-dependent MEF2D higher-order assembly during myogenesis

doi: 10.1038/s41467-023-37017-7

Figure Lengend Snippet: a Mef2D is extensively disordered and predicted to form liquid-liquid phase separated condensates. The Mef2D structure predicted by Alphafold indicates a small structured domain involving the N-terminal ~100 residues and most of the transactivation domain (TAD) contains is disordered. The regions promoting formation of liquid-like droplets by the FuzDrop method are marked by blue. The β-domain (magenta) appears as an ordered motif within the disordered transactivation region. FuzDrop predictions shown on the right panels indicate high droplet-promoting probability (p DP ) in particular for regions 155-268 residues and 341-520 residues, which are predicted to spontaneously form liquid-liquid phase separated condensates. The β-domain (magenta) and its flanking regions (cyan) are predicted to serve as ordered interaction motifs within the condensate (see also Supplementary Fig. ). In addition, the β-domain region is capable of sampling a multiplicity of binding modes (MBM), indicating its sensitivity to the cellular context. b Sequences of the designed Mef2D variants. The β-domain and its flanking regions are shown for the wild-type ( wt ) Mef2D (UniProt code: Q14814; https://legacy.uniprot.org/uniprot/Q14814 ; 265-301 residues), var1 and var2 with similar β-domain dynamics (gray), var3 and var4 with mobile β-domains (green), var5 - var8 with rigid β-domains (red) as compared to wild-type Mef2D. The sequence of the β-domain is magenta, mutated residues (orange) are highlighted. c Predicted β-domain disorder of Mef2D variants. Structural disorder in the unbound state of Mef2D were computed for the full protein sequence using the Espritz method as embedded in the FuzPred program and the p D values were averaged for residues 286-292. The var3 and var4 variants (green) are above the threshold between disorder and order (p D ≥ 0.3085 ). var1 (gray) has similar, var2 (gray) has slightly more mobile β-domain than the wild-type Mef2D (black). var5 - var8 variants (red) are predicted to have more rigid β-domain than the wild-type. d Droplet landscape of the Mef2D variants. The droplet landscape shows the droplet probability (p DP ) as a function of the multiplicity of binding modes (MBM) , . The assemblies below the diagonal are likely more solid-like, those above the diagonal are more liquid like . High MBM values indicate an increased likelihood to change between liquid-like and solid-like forms, for example in case of var8 . More mobile β-domain variants ( var3 , var4 , green diamonds) exhibit increased probability to form droplets (higher p DP ), whereas more rigid β-domain variants ( var5 - var8 , red triangles) more likely form solid-like states depending on the cellular conditions (high MBM).

Article Snippet: C2C12 cells were transfected with MEF2D specific CRISPR/Cas9 knockout and HDR plasmid constructs, targeting 3 different places in coding sequence (in exon# 3, 4 and 5; Santa Cruz Technology, Dallas, TX, USA).

Techniques: Sampling, Binding Assay, Sequencing

Luciferase activity normalised to galactosidase signal (Methods) is shown as a percentage of the wild-type (wt) control. Luciferase activity was measured in four biologically independent experiments, using three technical replicates in each with the same samples ( n = 12 samples in 4 independent experiments). The points represent individual measured data, the rectangles in the box plots present the median and the 25 and 75 percentile values, while the error bars point to 1 and 99%. The luciferase signal is shown as mean ± SE, significance (* p < 0.05; ** p < 0.01; # p < 0.005; ## p < 0.001) was computed using two-sided student t-test. The different variants are grouped by their β-domain dynamics properties (Fig. , Methods): var1 (gray diamond) and var2 (gray triangle) with similar β-domain dynamics; var3 (green diamond) and var4 (green triangle) with mobile β-domain; var5 (red diamond), var6 (red triangle), var7 (red circle) and var8 (red square) with rigid β-domain as compared to the wild-type. The β- variant is shown by blue diamond. a Transcriptional activity in non-differentiated C2C12 myoblasts. Variants with rigid β-domains show significantly higher transcriptional activity then the wild-type ( var5 178 ± 9.6, var6 135.6 ± 9.3, var7 141.6±8.1 and var8 140.8±11.5 %), while variants with mobile β-domains show slightly increased transcription activity ( var3 127.7 ± 4.9 and var4 123.9 ± 5.5 %) using n = 12 samples in 4 independent experiments. Significances ( var3 p = 0.0001, var4 p = 0.0012, var5 p = 5.2*10 −6 , var6 p = 0.0027, var7 p = 0.0003, var8 p = 0.0044; β-minus p = 1.52*10 −6 ) were computed using two-sided student t-test. b Transcriptional activity in differentiated C2C12 myotubes . var8 with rigid β-domain (red square) exhibits significantly higher transcriptional activity than the wild-type, while var3 (green diamond) and var4 (green triangle) with mobile β-domains, and var2 (gray triangle) with similar β-domain dynamics as the wild-type exhibit reduced transcriptional activity. ( n = 12 samples in 4 independent experiments). Significances ( var2 p = 2.9*10 −9 ; var3 p = 0.008; var4 p = 1.02*10 −7 ; var8 p = 0.0004) were computed using two-sided student t-test. c Lack of Mef2D blocks myotube formation in Mef2D knockout C2C12 cell line. Western blot images showing the lack of Mef2D, which are present endogenously in C2C12 cells. Three chosen stable KO cultures were followed through several passages to prove the stable lack of Mef2D (~70 kDa), while actin was used as inner control (~40 kDa). After 6 days of differentiation myotubes form in C2C12 cell line with endogeneous Mef2D (control, left panel), while cannot be observed in MEF2D KO cultures (right panel). Images were taken by transmitted microscopy, scale bars represent 400 µm. d Transcriptional activity in C2C12 KO cells. Rigid β-domain variants (red) have higher transcriptional activity than variants with similar dynamics to the wild-type (gray). Significances ( var4 p = 0.0175, var5 p = 0.0096, var6 p = 0.0365; var7 p = 0.0022; var8 p = 0.0071) were computed using two-sided student t-test using n = 9 samples in 3 independent experiments).

Journal: Nature Communications

Article Title: Alternatively spliced exon regulates context-dependent MEF2D higher-order assembly during myogenesis

doi: 10.1038/s41467-023-37017-7

Figure Lengend Snippet: Luciferase activity normalised to galactosidase signal (Methods) is shown as a percentage of the wild-type (wt) control. Luciferase activity was measured in four biologically independent experiments, using three technical replicates in each with the same samples ( n = 12 samples in 4 independent experiments). The points represent individual measured data, the rectangles in the box plots present the median and the 25 and 75 percentile values, while the error bars point to 1 and 99%. The luciferase signal is shown as mean ± SE, significance (* p < 0.05; ** p < 0.01; # p < 0.005; ## p < 0.001) was computed using two-sided student t-test. The different variants are grouped by their β-domain dynamics properties (Fig. , Methods): var1 (gray diamond) and var2 (gray triangle) with similar β-domain dynamics; var3 (green diamond) and var4 (green triangle) with mobile β-domain; var5 (red diamond), var6 (red triangle), var7 (red circle) and var8 (red square) with rigid β-domain as compared to the wild-type. The β- variant is shown by blue diamond. a Transcriptional activity in non-differentiated C2C12 myoblasts. Variants with rigid β-domains show significantly higher transcriptional activity then the wild-type ( var5 178 ± 9.6, var6 135.6 ± 9.3, var7 141.6±8.1 and var8 140.8±11.5 %), while variants with mobile β-domains show slightly increased transcription activity ( var3 127.7 ± 4.9 and var4 123.9 ± 5.5 %) using n = 12 samples in 4 independent experiments. Significances ( var3 p = 0.0001, var4 p = 0.0012, var5 p = 5.2*10 −6 , var6 p = 0.0027, var7 p = 0.0003, var8 p = 0.0044; β-minus p = 1.52*10 −6 ) were computed using two-sided student t-test. b Transcriptional activity in differentiated C2C12 myotubes . var8 with rigid β-domain (red square) exhibits significantly higher transcriptional activity than the wild-type, while var3 (green diamond) and var4 (green triangle) with mobile β-domains, and var2 (gray triangle) with similar β-domain dynamics as the wild-type exhibit reduced transcriptional activity. ( n = 12 samples in 4 independent experiments). Significances ( var2 p = 2.9*10 −9 ; var3 p = 0.008; var4 p = 1.02*10 −7 ; var8 p = 0.0004) were computed using two-sided student t-test. c Lack of Mef2D blocks myotube formation in Mef2D knockout C2C12 cell line. Western blot images showing the lack of Mef2D, which are present endogenously in C2C12 cells. Three chosen stable KO cultures were followed through several passages to prove the stable lack of Mef2D (~70 kDa), while actin was used as inner control (~40 kDa). After 6 days of differentiation myotubes form in C2C12 cell line with endogeneous Mef2D (control, left panel), while cannot be observed in MEF2D KO cultures (right panel). Images were taken by transmitted microscopy, scale bars represent 400 µm. d Transcriptional activity in C2C12 KO cells. Rigid β-domain variants (red) have higher transcriptional activity than variants with similar dynamics to the wild-type (gray). Significances ( var4 p = 0.0175, var5 p = 0.0096, var6 p = 0.0365; var7 p = 0.0022; var8 p = 0.0071) were computed using two-sided student t-test using n = 9 samples in 3 independent experiments).

Article Snippet: C2C12 cells were transfected with MEF2D specific CRISPR/Cas9 knockout and HDR plasmid constructs, targeting 3 different places in coding sequence (in exon# 3, 4 and 5; Santa Cruz Technology, Dallas, TX, USA).

Techniques: Luciferase, Activity Assay, Control, Variant Assay, Knock-Out, Western Blot, Microscopy

a Early stage of myotube development (day 2 - day 4). The number of multinucleated, long myotubes in the presence of overexpressed Mef2D variants. Representative fluorescent and transmitted images represent randomly selected visual fields and were used to determine the fusion index of the appropriate cultures. Each experiment was independently repeated two times with similar results, at least 15 randomly selected visual fields were analysed. Scale bar is 50 µm. b , c Protein expression of myogenic regulatory factors MyoD ( b ) and Desmin ( c ). Normalized protein expression during the differentiation of C2C12 cells. Protein expression was plotted as a percentage of their wild-type control in each day of differentiation. Data was derived from quadruplicate measurements ( n = 4 independent experiments), significances (* p = 0.0032; ** p = 0.0172 for panel b , and * p = 0.0149; ** p = 0.0002 for panel c ) were computed using two-sided student t-test as compared to the wild-type control on the given day of differentiation. b Protein expression of the early differentiation regulator MyoD. Variants with rigid β-domains ( var5 - var8 , red) exhibit higher level of MyoD expression on day 1 and day 2. Significant deviations ( var5 p = 0.0032; var8 p = 0.0172) were observed in case of var5 and var8 using two-sided student t-test as compared to the wild-type control on the given day of differentiation. c Protein expression of the late differentiation marker desmin. More rigid β-domain variants ( var5 p = 0.0149; var8 p = 0.0002, red) significantly increase desmin expression on days 1 and 2.

Journal: Nature Communications

Article Title: Alternatively spliced exon regulates context-dependent MEF2D higher-order assembly during myogenesis

doi: 10.1038/s41467-023-37017-7

Figure Lengend Snippet: a Early stage of myotube development (day 2 - day 4). The number of multinucleated, long myotubes in the presence of overexpressed Mef2D variants. Representative fluorescent and transmitted images represent randomly selected visual fields and were used to determine the fusion index of the appropriate cultures. Each experiment was independently repeated two times with similar results, at least 15 randomly selected visual fields were analysed. Scale bar is 50 µm. b , c Protein expression of myogenic regulatory factors MyoD ( b ) and Desmin ( c ). Normalized protein expression during the differentiation of C2C12 cells. Protein expression was plotted as a percentage of their wild-type control in each day of differentiation. Data was derived from quadruplicate measurements ( n = 4 independent experiments), significances (* p = 0.0032; ** p = 0.0172 for panel b , and * p = 0.0149; ** p = 0.0002 for panel c ) were computed using two-sided student t-test as compared to the wild-type control on the given day of differentiation. b Protein expression of the early differentiation regulator MyoD. Variants with rigid β-domains ( var5 - var8 , red) exhibit higher level of MyoD expression on day 1 and day 2. Significant deviations ( var5 p = 0.0032; var8 p = 0.0172) were observed in case of var5 and var8 using two-sided student t-test as compared to the wild-type control on the given day of differentiation. c Protein expression of the late differentiation marker desmin. More rigid β-domain variants ( var5 p = 0.0149; var8 p = 0.0002, red) significantly increase desmin expression on days 1 and 2.

Article Snippet: C2C12 cells were transfected with MEF2D specific CRISPR/Cas9 knockout and HDR plasmid constructs, targeting 3 different places in coding sequence (in exon# 3, 4 and 5; Santa Cruz Technology, Dallas, TX, USA).

Techniques: Expressing, Control, Derivative Assay, Marker

a Mef2D foci in the nucleus and cytoplasm. Subcellular distribution of Mef2D wt , var3 , var4 and var8 in C2C12 cells grown in cycling or differentiating medium exhibit foci formation in both the nucleus and cytoplasm. Higher-order assembly is most pronounced in case of var8 with rigid β-domain, but is also observed in case of var3 and var4 with mobile β-domain. 24 hrs post-transfection cells were fixed and stained with an antibody specific for Mef2D. Nucleic acid was stained using DAPI. The scale bar is 10 μm on the representative images. The experiment was performed four times (cycling medium) and three times (differentiating medium). Quantification is shown in panel b . b Quantification of MEF2D cells with cytoplasmic higher-order structures (foci). The percentage of Mef2D overexpressing cells with cytoplasmic aggregates is significantly higher in case of var8 with rigid β-domain. Cycling C2C12 cells: n = 4, ± s.e.m.; differentiating C2C12 cells: n = 3 independent experiments, ± s.e.m. Total number of cells counted > 150. Significances were computed by one-way ANOVA followed by Bonferroni-Holm Posthoc in reference to wt : var3 p = 0.13 (cycling) and p = 0.87 (differentiated), var4 p = 0.09 (cycling) and p = 0.60 (differentiated), var8 p = 0.04 (cycling) and p = 0.04 (differentiated). c , d Analysis of mobility of Mef2D higher-order assemblies in nuclear foci ( c ) and cytoplasmic foci ( d ). Mobility was assessed by fluorescence recovery after photobleaching (FRAP) performed after 24 hours post-transfection of GFP-tagged MEF2D wt, var3 , var4 and var8 in C2C12 cells. The mean of the FRAP curve +/- standard error of the mean (s.e.m.) is shown. c Number of nuclear foci analyzed: wt (3); var3 (3); var4 (3); var8 (3). d number of cytoplasmic aggregates analyzed: wt (11); var3 (10); var4 (10); var8 (9). All Mef2D proteins show high mobility inside the nuclear foci ( c ) and nucleoplasm (Supplementary Fig. ). This is in sharp contrast with the low mobility inside cytoplasmic foci ( d ).

Journal: Nature Communications

Article Title: Alternatively spliced exon regulates context-dependent MEF2D higher-order assembly during myogenesis

doi: 10.1038/s41467-023-37017-7

Figure Lengend Snippet: a Mef2D foci in the nucleus and cytoplasm. Subcellular distribution of Mef2D wt , var3 , var4 and var8 in C2C12 cells grown in cycling or differentiating medium exhibit foci formation in both the nucleus and cytoplasm. Higher-order assembly is most pronounced in case of var8 with rigid β-domain, but is also observed in case of var3 and var4 with mobile β-domain. 24 hrs post-transfection cells were fixed and stained with an antibody specific for Mef2D. Nucleic acid was stained using DAPI. The scale bar is 10 μm on the representative images. The experiment was performed four times (cycling medium) and three times (differentiating medium). Quantification is shown in panel b . b Quantification of MEF2D cells with cytoplasmic higher-order structures (foci). The percentage of Mef2D overexpressing cells with cytoplasmic aggregates is significantly higher in case of var8 with rigid β-domain. Cycling C2C12 cells: n = 4, ± s.e.m.; differentiating C2C12 cells: n = 3 independent experiments, ± s.e.m. Total number of cells counted > 150. Significances were computed by one-way ANOVA followed by Bonferroni-Holm Posthoc in reference to wt : var3 p = 0.13 (cycling) and p = 0.87 (differentiated), var4 p = 0.09 (cycling) and p = 0.60 (differentiated), var8 p = 0.04 (cycling) and p = 0.04 (differentiated). c , d Analysis of mobility of Mef2D higher-order assemblies in nuclear foci ( c ) and cytoplasmic foci ( d ). Mobility was assessed by fluorescence recovery after photobleaching (FRAP) performed after 24 hours post-transfection of GFP-tagged MEF2D wt, var3 , var4 and var8 in C2C12 cells. The mean of the FRAP curve +/- standard error of the mean (s.e.m.) is shown. c Number of nuclear foci analyzed: wt (3); var3 (3); var4 (3); var8 (3). d number of cytoplasmic aggregates analyzed: wt (11); var3 (10); var4 (10); var8 (9). All Mef2D proteins show high mobility inside the nuclear foci ( c ) and nucleoplasm (Supplementary Fig. ). This is in sharp contrast with the low mobility inside cytoplasmic foci ( d ).

Article Snippet: C2C12 cells were transfected with MEF2D specific CRISPR/Cas9 knockout and HDR plasmid constructs, targeting 3 different places in coding sequence (in exon# 3, 4 and 5; Santa Cruz Technology, Dallas, TX, USA).

Techniques: Transfection, Staining, Fluorescence

Conformational analysis was performed using the 70-100 ns trajectory of each replica (9000 snapshots) (Methods). a Contacts maps of the clusters. Mef2D wt , var3 , var4 and var8 peptides exhibit distinct intra-molecular interaction patterns (Methods). The β-domain (blue) contributes to structure organisation of var8 and to lesser extent to var4 , while does not form persisting contacts in var3 (see also Supplementary Fig. ). Color scales indicate the number of snapshots in the clusters, with the given contact sampled. b Representative structures of the of Mef2D variant peptides. More compact structures are formed through interactions of the β-domain (blue), such as in case of var8 and var4 , while extended structures, such as in case of var3 sample variable interactions outside the β-domain. β-domain residues are displayed in blue, residues mutated in the different variants are orange labelled.

Journal: Nature Communications

Article Title: Alternatively spliced exon regulates context-dependent MEF2D higher-order assembly during myogenesis

doi: 10.1038/s41467-023-37017-7

Figure Lengend Snippet: Conformational analysis was performed using the 70-100 ns trajectory of each replica (9000 snapshots) (Methods). a Contacts maps of the clusters. Mef2D wt , var3 , var4 and var8 peptides exhibit distinct intra-molecular interaction patterns (Methods). The β-domain (blue) contributes to structure organisation of var8 and to lesser extent to var4 , while does not form persisting contacts in var3 (see also Supplementary Fig. ). Color scales indicate the number of snapshots in the clusters, with the given contact sampled. b Representative structures of the of Mef2D variant peptides. More compact structures are formed through interactions of the β-domain (blue), such as in case of var8 and var4 , while extended structures, such as in case of var3 sample variable interactions outside the β-domain. β-domain residues are displayed in blue, residues mutated in the different variants are orange labelled.

Article Snippet: C2C12 cells were transfected with MEF2D specific CRISPR/Cas9 knockout and HDR plasmid constructs, targeting 3 different places in coding sequence (in exon# 3, 4 and 5; Santa Cruz Technology, Dallas, TX, USA).

Techniques: Variant Assay

Fig. 5. Dex reversed H/R-induced upre gulation of miR-665 and downregulation of MEF2D. (A-B) Expressions of miR-665 and MEF2D mRNA were examined by qRT-PCR. (C-D) Expressions of MEF2D protein were detected by Western blot. Quantitative analyses of protein band intensity. GAPDH served as an internal control for sample loading. (E) Predicted duplex formation between MEF2D 3′- UTR and miR-665. (F) Dual luciferase gene reporter assay manifested that miR- 665 could directly bind with MEF2D. (n = 3 per group). **p < 0.01, ***p < 0.001, ****p < 0.0001. qRT- PCR, quantitative reverse transcription PCR; UTR, untranslated region; MEF2D, myocyte enhancer factor 2D.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Article Title: Dexmedetomidine abates myocardial ischemia reperfusion injury through inhibition of pyroptosis via regulation of miR-665/MEF2D/Nrf2 axis.

doi: 10.1016/j.biopha.2023.115255

Figure Lengend Snippet: Fig. 5. Dex reversed H/R-induced upre gulation of miR-665 and downregulation of MEF2D. (A-B) Expressions of miR-665 and MEF2D mRNA were examined by qRT-PCR. (C-D) Expressions of MEF2D protein were detected by Western blot. Quantitative analyses of protein band intensity. GAPDH served as an internal control for sample loading. (E) Predicted duplex formation between MEF2D 3′- UTR and miR-665. (F) Dual luciferase gene reporter assay manifested that miR- 665 could directly bind with MEF2D. (n = 3 per group). **p < 0.01, ***p < 0.001, ****p < 0.0001. qRT- PCR, quantitative reverse transcription PCR; UTR, untranslated region; MEF2D, myocyte enhancer factor 2D.

Article Snippet: The proteins, which were subjected to 10% SDS-PAGE gels, were transferred onto PVDF membranes and probed using primary antibodies against MEF2D (1:1000, Affinity, AF7888), Nrf2(1:2000, Affinity, AF0639), NLRP3 (1:1000, Abcam, Ab263899), ASC (1:1000, Affinity, DF6304), cleavedcaspase-1 (1:1000, Affinity, AF4005), GSDMD (1:1000, Abclonal, A20197), IL-1β (1:1000, Genetex, GTX130021), IL-18(1:1000, Affinity, DF6252), Lamin B(1:1000, Boster, BA1228) and GAPDH (1:1000, GOODHERE, AB-P-R 001) as the loading control overnight at 4 ◦C.

Techniques: Quantitative RT-PCR, Western Blot, Control, Luciferase, Reporter Assay, Reverse Transcription

Fig. 6. Dex improved cell viability and decreased apoptosis of H9c2 cells undergoing H/R via downregulation of miR-665 followed by upregulation of MEF2D. The H9c2 cells were transfected with miR-665mimics or co-transfection of miR-665mimics with pcDNA-MEF2D for 48 h before treatment with 10 nM Dex for 1 h. (A) The effects of miR-665 overexpression or miR-665 and MEF2D simultaneous overexpression on morphology of H9c2 cells in each group were observed using an inverted microscope (scale bars, 100 µm). (B) The effects of miR-665 overexpression or miR-665 and MEF2D simultaneous overexpression on the cell viability were detected using CCK-8 assay. (C-F) The effects of miR-665 overexpression or miR-665 and MEF2D simultaneous overexpression on the cell apoptosis were gauged by flow cytometry. The apoptotic rates were presented as addition of the percentages of cells at early apoptotic phase and late apoptotic phase. Data are shown as the mean ± SD of three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. ns, not significant.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Article Title: Dexmedetomidine abates myocardial ischemia reperfusion injury through inhibition of pyroptosis via regulation of miR-665/MEF2D/Nrf2 axis.

doi: 10.1016/j.biopha.2023.115255

Figure Lengend Snippet: Fig. 6. Dex improved cell viability and decreased apoptosis of H9c2 cells undergoing H/R via downregulation of miR-665 followed by upregulation of MEF2D. The H9c2 cells were transfected with miR-665mimics or co-transfection of miR-665mimics with pcDNA-MEF2D for 48 h before treatment with 10 nM Dex for 1 h. (A) The effects of miR-665 overexpression or miR-665 and MEF2D simultaneous overexpression on morphology of H9c2 cells in each group were observed using an inverted microscope (scale bars, 100 µm). (B) The effects of miR-665 overexpression or miR-665 and MEF2D simultaneous overexpression on the cell viability were detected using CCK-8 assay. (C-F) The effects of miR-665 overexpression or miR-665 and MEF2D simultaneous overexpression on the cell apoptosis were gauged by flow cytometry. The apoptotic rates were presented as addition of the percentages of cells at early apoptotic phase and late apoptotic phase. Data are shown as the mean ± SD of three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. ns, not significant.

Article Snippet: The proteins, which were subjected to 10% SDS-PAGE gels, were transferred onto PVDF membranes and probed using primary antibodies against MEF2D (1:1000, Affinity, AF7888), Nrf2(1:2000, Affinity, AF0639), NLRP3 (1:1000, Abcam, Ab263899), ASC (1:1000, Affinity, DF6304), cleavedcaspase-1 (1:1000, Affinity, AF4005), GSDMD (1:1000, Abclonal, A20197), IL-1β (1:1000, Genetex, GTX130021), IL-18(1:1000, Affinity, DF6252), Lamin B(1:1000, Boster, BA1228) and GAPDH (1:1000, GOODHERE, AB-P-R 001) as the loading control overnight at 4 ◦C.

Techniques: Transfection, Cotransfection, Over Expression, Inverted Microscopy, CCK-8 Assay, Flow Cytometry

Fig. 7. Dex protected against pyroptosis of H9c2 cells undergoing H/R via downregulation of miR-665 followed by upregulation of MEF2D. (A) Protein bands of MEF2D, IL-1β, IL-18, NLRP3, ASC, C-Caspase-1, and GSDMD were evaluated by Western blot. (B-C) Expressions of miR-665 and MEF2D mRNA were detected by qRT- PCR. (D-J) Quantitative analyses of protein band intensities of MEF2D, IL-1β, IL-18, NLRP3, ASC, C-Caspase-1, and GSDMD. GAPDH served as an internal control for sample loading. Data are shown as the mean ± SD of three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. ns, not significant.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Article Title: Dexmedetomidine abates myocardial ischemia reperfusion injury through inhibition of pyroptosis via regulation of miR-665/MEF2D/Nrf2 axis.

doi: 10.1016/j.biopha.2023.115255

Figure Lengend Snippet: Fig. 7. Dex protected against pyroptosis of H9c2 cells undergoing H/R via downregulation of miR-665 followed by upregulation of MEF2D. (A) Protein bands of MEF2D, IL-1β, IL-18, NLRP3, ASC, C-Caspase-1, and GSDMD were evaluated by Western blot. (B-C) Expressions of miR-665 and MEF2D mRNA were detected by qRT- PCR. (D-J) Quantitative analyses of protein band intensities of MEF2D, IL-1β, IL-18, NLRP3, ASC, C-Caspase-1, and GSDMD. GAPDH served as an internal control for sample loading. Data are shown as the mean ± SD of three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. ns, not significant.

Article Snippet: The proteins, which were subjected to 10% SDS-PAGE gels, were transferred onto PVDF membranes and probed using primary antibodies against MEF2D (1:1000, Affinity, AF7888), Nrf2(1:2000, Affinity, AF0639), NLRP3 (1:1000, Abcam, Ab263899), ASC (1:1000, Affinity, DF6304), cleavedcaspase-1 (1:1000, Affinity, AF4005), GSDMD (1:1000, Abclonal, A20197), IL-1β (1:1000, Genetex, GTX130021), IL-18(1:1000, Affinity, DF6252), Lamin B(1:1000, Boster, BA1228) and GAPDH (1:1000, GOODHERE, AB-P-R 001) as the loading control overnight at 4 ◦C.

Techniques: Western Blot, Quantitative RT-PCR, Control

Fig. 8. Dex facilitated nuclear translocation of Nrf2 regulated by MEF2D in H/R-treated H9c2 cells. (A) Expressions of cytoplasmic Nrf2 and nuclear Nrf2 proteins were determined by Western blot in H/R-treated H9c2 cells subjected to Dex pretreatment. GAPDH and Lamin B were used as internal references for sample loading respectively. (B-C) Quantitative analyses of the expression levels of cytoplasmic Nrf2 and nuclear Nrf2. (D) Expressions of cytoplasmic Nrf2 and nuclear Nrf2 proteins were detected by Western blot in H/R-treated H9c2 cells undergoing Dex pretreatment and transfection of miR-665mimics or co-transfection of miR-665mimics with pcDNA-MEF2D respectively. GAPDH and Histone3 acted as internal references for sample loading respectively. (E-F) Quantitative analyses of the expression levels of cytoplasmic Nrf2 and nuclear Nrf2. Data are shown as the mean ± SD of three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. ns, not significant. Nrf2, nuclear factor erythroid 2-related factor 2.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Article Title: Dexmedetomidine abates myocardial ischemia reperfusion injury through inhibition of pyroptosis via regulation of miR-665/MEF2D/Nrf2 axis.

doi: 10.1016/j.biopha.2023.115255

Figure Lengend Snippet: Fig. 8. Dex facilitated nuclear translocation of Nrf2 regulated by MEF2D in H/R-treated H9c2 cells. (A) Expressions of cytoplasmic Nrf2 and nuclear Nrf2 proteins were determined by Western blot in H/R-treated H9c2 cells subjected to Dex pretreatment. GAPDH and Lamin B were used as internal references for sample loading respectively. (B-C) Quantitative analyses of the expression levels of cytoplasmic Nrf2 and nuclear Nrf2. (D) Expressions of cytoplasmic Nrf2 and nuclear Nrf2 proteins were detected by Western blot in H/R-treated H9c2 cells undergoing Dex pretreatment and transfection of miR-665mimics or co-transfection of miR-665mimics with pcDNA-MEF2D respectively. GAPDH and Histone3 acted as internal references for sample loading respectively. (E-F) Quantitative analyses of the expression levels of cytoplasmic Nrf2 and nuclear Nrf2. Data are shown as the mean ± SD of three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. ns, not significant. Nrf2, nuclear factor erythroid 2-related factor 2.

Article Snippet: The proteins, which were subjected to 10% SDS-PAGE gels, were transferred onto PVDF membranes and probed using primary antibodies against MEF2D (1:1000, Affinity, AF7888), Nrf2(1:2000, Affinity, AF0639), NLRP3 (1:1000, Abcam, Ab263899), ASC (1:1000, Affinity, DF6304), cleavedcaspase-1 (1:1000, Affinity, AF4005), GSDMD (1:1000, Abclonal, A20197), IL-1β (1:1000, Genetex, GTX130021), IL-18(1:1000, Affinity, DF6252), Lamin B(1:1000, Boster, BA1228) and GAPDH (1:1000, GOODHERE, AB-P-R 001) as the loading control overnight at 4 ◦C.

Techniques: Translocation Assay, Western Blot, Expressing, Transfection, Cotransfection

Neuritin induces LGI1 expression through HDAC5 phosphorylation and MEF2D-mediated transcription. (A) Representative immunoblots of p-HDAC5 in hippocampal neurons (DIV7) treated with various concentrations of recombinant soluble neuritin for 30 min or with KCl (30 mM) for 6 h ( n = 4–5). (B) Representative immunoblots of p-HDAC5 from hippocampal neurons pretreated with KN-62 (30 μM) or Gö6976 (1 μM) for 30 min and incubated with soluble neuritin or KCl ( n = 3). (C–E) Luciferase assays. MEF2-luiciferase activity was normalized with Renilla luciferase activity and is depicted relative to the control (CTL), and expressed as fold change relative to the CTL. (C) Mouse hippocampal neurons (DIV4) transfected with pGL3-Luc and pGL3-MEF2-Luc were treated with neuritin for the indicated times ( n = 4). (D) Mouse hippocampal neurons transfected with pGL3-Luc and PGL3- MEF2 -Luc were treated with neuritin in the presence of KN-62 or Gö6976 ( n = 4). (E) Neurons transfected with pGL3-Luc, pGL3- MEF2 -Luc, pCl-neo, pCl-neo- HDAC5 -WT or pCl-neo- HDAC5 -S/A were treated with recombinant soluble neuritin for 1 h ( n = 7). (F) ChIP assays. Binding of HDAC5 to the Lgi1 promoter was decreased in recombinant soluble neuritin-treated mouse hippocampal neurons ( n = 3). (G) IP. Neurons (DIV4) transfected with Myc- HDAC5 were treated with recombinant soluble neuritin (200 ng/ml) for 1 h. Binding of HDAC5 to MEF2D in mouse hippocampal neurons was decreased by recombinant soluble neuritin treatment ( n = 3). (H) Neurons (DIV4) transfected with control siRNA and Mef2d siRNA were treated with recombinant soluble neuritin (200 ng/ml) for 6 h. Representative immunoblots (Left) and quantitative data (Right) for MEF2D or LGI1 protein expression ( n = 3). In (A)–(H), Data are represented as mean ± SEM; * p < 0.05, ** p < 0.01, *** p < 0.001 compared with CTL, # p < 0.05, ### p < 0.001 compared with recombinant soluble neuritin treatment. Statistics: Student's t -test (A, C, F and G). One-way ANOVA (B) or two-way ANOVA (D) followed by LSD posttest. Two-way ANOVA followed by Newman-Keuls posttest (E) or Bonferroni posttest (H). Statistics detailed in .

Journal: Neurobiology of Stress

Article Title: LGI1 governs neuritin-mediated resilience to chronic stress

doi: 10.1016/j.ynstr.2021.100373

Figure Lengend Snippet: Neuritin induces LGI1 expression through HDAC5 phosphorylation and MEF2D-mediated transcription. (A) Representative immunoblots of p-HDAC5 in hippocampal neurons (DIV7) treated with various concentrations of recombinant soluble neuritin for 30 min or with KCl (30 mM) for 6 h ( n = 4–5). (B) Representative immunoblots of p-HDAC5 from hippocampal neurons pretreated with KN-62 (30 μM) or Gö6976 (1 μM) for 30 min and incubated with soluble neuritin or KCl ( n = 3). (C–E) Luciferase assays. MEF2-luiciferase activity was normalized with Renilla luciferase activity and is depicted relative to the control (CTL), and expressed as fold change relative to the CTL. (C) Mouse hippocampal neurons (DIV4) transfected with pGL3-Luc and pGL3-MEF2-Luc were treated with neuritin for the indicated times ( n = 4). (D) Mouse hippocampal neurons transfected with pGL3-Luc and PGL3- MEF2 -Luc were treated with neuritin in the presence of KN-62 or Gö6976 ( n = 4). (E) Neurons transfected with pGL3-Luc, pGL3- MEF2 -Luc, pCl-neo, pCl-neo- HDAC5 -WT or pCl-neo- HDAC5 -S/A were treated with recombinant soluble neuritin for 1 h ( n = 7). (F) ChIP assays. Binding of HDAC5 to the Lgi1 promoter was decreased in recombinant soluble neuritin-treated mouse hippocampal neurons ( n = 3). (G) IP. Neurons (DIV4) transfected with Myc- HDAC5 were treated with recombinant soluble neuritin (200 ng/ml) for 1 h. Binding of HDAC5 to MEF2D in mouse hippocampal neurons was decreased by recombinant soluble neuritin treatment ( n = 3). (H) Neurons (DIV4) transfected with control siRNA and Mef2d siRNA were treated with recombinant soluble neuritin (200 ng/ml) for 6 h. Representative immunoblots (Left) and quantitative data (Right) for MEF2D or LGI1 protein expression ( n = 3). In (A)–(H), Data are represented as mean ± SEM; * p < 0.05, ** p < 0.01, *** p < 0.001 compared with CTL, # p < 0.05, ### p < 0.001 compared with recombinant soluble neuritin treatment. Statistics: Student's t -test (A, C, F and G). One-way ANOVA (B) or two-way ANOVA (D) followed by LSD posttest. Two-way ANOVA followed by Newman-Keuls posttest (E) or Bonferroni posttest (H). Statistics detailed in .

Article Snippet: Control siRNA (SC-37007, Santa Cruz, TX, USA) and Mef2d siRNA (SC-38065, Santa Cruz) were solubilized in RNAse-free water.

Techniques: Expressing, Phospho-proteomics, Western Blot, Recombinant, Incubation, Luciferase, Activity Assay, Control, Transfection, Binding Assay

Exogenous stable expression of GRIP-1 sense and antisense in C2C12 myogenic cells demonstrates that GRIP-1 expression is necessary for terminal skeletal muscle cell differentiation. Total RNA was isolated from both normal C2C12 and stably transfected C2:GRIP-1 sense and antisense cells at the PMB and CMB stage (∼50% and 100% confluent, respectively) cultured in growth medium, and at a stage 72 hr/3 days after the withdrawal of serum (i.e., propagated in differentiation medium, MT-3). RNA samples were blotted and probed with 32P-radiolabeled cDNA encoding GAPDH, myoD, myogenin, cyclinD1, and p21. MEF-2 proteins were detected by Western blot with 30 μg of nuclear proteins from each sample using a rabbit antibody to MEF-2 (Santa Cruz C-21), which was generated against MEF-2A but which cross-reacts with mouse/human MEF-2A, MEF-2C, and MEF-2D. (GM) Growth medium (DMEM containing 20% FCS); (DM) differentiation medium (DMEM containing 2% horse serum).

Journal:

Article Title: The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation

doi:

Figure Lengend Snippet: Exogenous stable expression of GRIP-1 sense and antisense in C2C12 myogenic cells demonstrates that GRIP-1 expression is necessary for terminal skeletal muscle cell differentiation. Total RNA was isolated from both normal C2C12 and stably transfected C2:GRIP-1 sense and antisense cells at the PMB and CMB stage (∼50% and 100% confluent, respectively) cultured in growth medium, and at a stage 72 hr/3 days after the withdrawal of serum (i.e., propagated in differentiation medium, MT-3). RNA samples were blotted and probed with 32P-radiolabeled cDNA encoding GAPDH, myoD, myogenin, cyclinD1, and p21. MEF-2 proteins were detected by Western blot with 30 μg of nuclear proteins from each sample using a rabbit antibody to MEF-2 (Santa Cruz C-21), which was generated against MEF-2A but which cross-reacts with mouse/human MEF-2A, MEF-2C, and MEF-2D. (GM) Growth medium (DMEM containing 20% FCS); (DM) differentiation medium (DMEM containing 2% horse serum).

Article Snippet: MEF-2 proteins were detected by Western blot with 30 μg of nuclear proteins from each sample using a rabbit antibody to MEF-2 (Santa Cruz C-21), which was generated against MEF-2A but which cross-reacts with mouse/human MEF-2A, MEF-2C, and MEF-2D. (GM) Growth medium (DMEM containing 20% FCS); (DM) differentiation medium (DMEM containing 2% horse serum).

Techniques: Expressing, Cell Differentiation, Isolation, Stable Transfection, Transfection, Cell Culture, Western Blot, Generated